破解基层慢性阻塞性肺疾病早诊难题：从公卫政策到防治体系建设的思考

doi:10.3969/j.issn.1006-5725.2025.16.001

Abstract

Abstract:

Chronic obstructive pulmonary disease （COPD） is a widespread chronic inflammatory respiratory condition characterized by high morbidity， affecting approximately 100 million individuals in China. It represents a significant public health concern and imposes considerable socioeconomic costs. Historically， the rate of early diagnosis for COPD has been low， presenting a persistent challenge in clinical practice. Enhancing early detection therefore remains a critical and urgent priority. This study provides a comprehensive review of existing national-level policies aimed at improving early COPD diagnosis within primary healthcare settings， as well as their regional implementation status. The dual objectives of this analysis are to support the enhancement of early diagnosis rates and to contribute to the optimization of COPD clinical management frameworks.

Key words: COPD, early diagnosis, grassroots level, clinical management frameworks

CLC Number:

R563

Zhaoqian GONG,Wenqu ZHAO,Yaoxin CHEN,Haijin. ZHAO. Addressing the challenge of early COPD diagnosis at the primary care level： Reflections from public health policies to healthcare system development[J]. The Journal of Practical Medicine, 2025, 41(16): 2441-2446.

References 28

[1]	ADELOYE D， SONG P， ZHU Y， et al. Global， regional， and national prevalence of， and risk factors for， chronic obstructive pulmonary disease （COPD） in 2019： A systematic review and modelling analysis［J］. Lancet Respir Med， 2022，10（5）：447-458. doi:10.1016/s2213-2600(21)00511-7 doi: 10.1016/s2213-2600(21)00511-7
[2]	STOLZ D， MKOROMBINDO T， SCHUMANN D M， et al. Towards the elimination of chronic obstructive pulmonary disease： A Lancet Commission［J］. Lancet， 2022，400（10356）：921-972. doi:10.1016/s0140-6736(22)01273-9 doi: 10.1016/s0140-6736(22)01273-9
[3]	FANG L， GAO P， BAO H， et al. Chronic obstructive pulmonary disease in China： A nationwide prevalence study［J］. Lancet Respir Med， 2018，6（6）：421-430. doi:10.1016/s2213-2600(18)30103-6 doi: 10.1016/s2213-2600(18)30103-6
[4]	WANG C， XU J， YANG L， et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China （the China Pulmonary Health ［CPH］ study）： A national cross-sectional study［J］. Lancet， 2018，391（10131）：1706-1717. doi:10.1016/s0140-6736(18)30841-9 doi: 10.1016/s0140-6736(18)30841-9
[5]	王凌伟，陈荣昌. 基层慢阻肺早期筛查和早期诊断的现状与对策［J］. 中华健康管理学杂志， 2022，16（4）：217-221.
[6]	彭显如，黄敏於，赵文驱，等. 首诊慢阻肺错失早期诊断时间与疾病严重程度相关［J］. 南方医科大学学报， 2018，38（12）：1448-1452.
[7]	CHEN Q， FAN Y， HUANG K， et al. Cost-effectiveness of population-based screening for chronic obstructive pulmonary disease in China： A simulation modeling study［J］. Lancet Reg Health West Pac， 2024， 46：101065. doi:10.1016/j.lanwpc.2024.101065 doi: 10.1016/j.lanwpc.2024.101065
[8]	李晓晨，刘先胜. 慢性阻塞性肺疾病全球创议2018更新与临床实践［J］. 临床内科杂志， 2018， 35（11）：729-732.
[9]	WANG C， QI W， YANG T， et al. The care cascade of chronic obstructive pulmonary disease in China： A cross-sectional study of individual-level data at enrolment into the national 'Happy Breathing' Programme［J］. EClinicalMedicine， 2024，74：102597. doi:10.1016/j.eclinm.2024.102597 doi: 10.1016/j.eclinm.2024.102597
[10]	唐星瑶，黄可，李薇，等. 河南省驻马店市基层医疗机构医生慢性阻塞性肺疾病知识掌握情况及影响因素调查研究［J］. 中华全科医师杂志， 2022，21（5）：422-429.
[11]	文富强，雷玲子. 我国临床医生对慢性阻塞性肺疾病认知现状与应对策略［J］. 西部医学， 2021，33（1）：1-3.
[12]	潘君，杨路莹，胡宁，等. 基层医疗卫生机构医务人员对慢性阻塞性肺疾病诊疗能力的调查研究［J］. 中国临床医生杂志， 2024， 52（6）：645-650.
[13]	上海市医学会呼吸分会基层呼吸疾病防治联盟. 上海市社区医生肺功能知识问卷调查［J］. 中国呼吸与危重监护杂志， 2018， 17（2）：165-168.
[14]	张冬莹，高怡，简文华，等. 肺功能检查技术在基层医疗卫生机构推广可行性及建议［J］. 中国全科医学， 2020， 23（29）：3638-3643.
[15]	中国县域慢性阻塞性肺疾病筛查专家共识编写专家组，中国医师协会呼吸医师分会基层工作委员会. 中国县域慢性阻塞性肺疾病筛查专家共识（2020年）［J］. 中华医学杂志， 2021， 101（14）：989-994.
[16]	国家卫生健康委员会. 健康中国行动——慢性呼吸系统疾病防治行动实施方案（2024—2030年）（第二部分）［J］. 中国病毒病杂志， 2025， 15（2）：157.
[17]	国家卫生健康委、财政部、国家中医药局、国家疾控局. 关于做好2024年基本公共卫生服务工作的通知［J］. 中华人民共和国国家卫生健康委员会公报， 2024（9）：8-10.
[18]	李薇，黄可，潘君，等. “三大国家级项目”共筑中国慢性阻塞性肺疾病防治长城［J］. 中国临床医生杂志， 2022， 50（7）：753-754.
[19]	王群，叶梅毅，李祖平，等. 区域医学检验中心信息化平台建设的发展现状与挑战［J］. 临床医药实践， 2025， 34（1）：43-46.
[20]	DAS N， HAPPAERTS S， GYSELINCK I， et al. Collaboration between explainable artificial intelligence and pulmonologists improves the accuracy of pulmonary function test interpretation［J］. Eur Respir J， 2023，61（5）：2201720. doi:10.1183/13993003.01720-2022 doi: 10.1183/13993003.01720-2022
[21]	中华医学会，中华医学会杂志社，中华医学会全科医学分会，等. 慢性阻塞性肺疾病基层诊疗指南（2018年）［J］. 中华全科医师杂志， 2018，17（11）：856-870.
[22]	MA Y， ZHAN Z， CHEN Y， et al. Machine learning-assisted construction of COPD self-evaluation questionnaire （COPD-EQ）： A national multicentre study in China［J］. J Glob Health， 2025， 15：4052. doi:10.7189/jogh.15.04052 doi: 10.7189/jogh.15.04052
[23]	梁雪玲，何平，曹晶晶，等. 医院-社区-家庭-个人的慢阻肺防控体系对慢阻肺患病率、知晓率及准确性的影响［J］. 广东医学， 2023，44（10）：1279-1282.
[24]	LEVENTHAL H， LEVENTHAL E A， CONTRADA R J. Self-regulation， health， and behavior： A perceptual-cognitive approach［J］. Psychol Health， 1998， 13（4）：717–733. doi:10.1080/08870449808407425 doi: 10.1080/08870449808407425
[25]	XIONG C， JIANG C， ZHANG H， et al. Self-management and illness perception among cervical cancer patients： A cross-sectional study［J］. Int J Nurs Pract， 2023，29（3）：e13134. doi:10.1111/ijn.13134 doi: 10.1111/ijn.13134
[26]	HUANG L M， TAN C Y， CHEN X， et al. A Qualitative Study on Illness Perception and Coping Behaviors Among Patients with Chronic Obstructive Pulmonary Disease： Implications for Intervention［J］. Int J Chron Obstruct Pulmon Dis， 2024， 19：2467-2479. doi:10.2147/copd.s473790 doi: 10.2147/copd.s473790
[27]	WU J， NIU H， DUAN S， et al. Current status of pharmacists in community pharmacies in China in the health management of chronic respiratory diseases［J］. BMC Public Health， 2025， 25（1）：1052. doi:10.1186/s12889-025-22272-8 doi: 10.1186/s12889-025-22272-8
[28]	张春瑜，贾存波，方方，等. 继续教育对基层医务人员有关慢性阻塞性肺疾病相关认知的影响研究［J］. 中国临床医生杂志， 2022， 50（2）：145-147.

Addressing the challenge of early COPD diagnosis at the primary care level： Reflections from public health policies to healthcare system development

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 28

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Wenfang HE,Xun ZHOU,Meizhu DING,Yiping CHEN,Qianli LIU,Xinyuan. TAN. Application of the "ASK⁃T" aspiration prevention management model in reducing the risk of aspiration in elderly patients with chronic obstructive pulmonary disease （COPD） complicated by dysphagia [J]. The Journal of Practical Medicine, 2025, 41(3): 434-441.
[2]	Jingwen LAI,Yuchuan ZHAO,Zhuhua WU,Xunxun CHEN,Kehao PENG,Yuhui CHEN,Ran WEI,Xiaoyu LAI,Jingyu. WANG. Research advances and challenges in tuberculosis⁃associated extracellular vesicle biomarkers [J]. The Journal of Practical Medicine, 2025, 41(14): 2278-2284.
[3]	Zhengzhang GUI,Lu YE,Yang ZHOU,Ling WANG,Yifeng JIN. A comparative study on spirometry and type 2 inflammatory markers in cough⁃variant asthma， asthma⁃COPD overlap， and classic asthma [J]. The Journal of Practical Medicine, 2025, 41(13): 2065-2072.
[4]	Long WANG,Yingmin WU,Sha SHANG,Lu WANG. The diagnostic value and clinical research of 5′⁃tRF⁃GlyGCC in the early stage of colorectal cancer [J]. The Journal of Practical Medicine, 2025, 41(11): 1730-1735.
[5]	Weifeng LIU,Zheng DAI,Yibin ZHOU,Kaiwen FENG,Kai WEI,Gule SUN,Dongrong YANG,Jin. ZHU. The value of urine protein kinase Y⁃linked gene promoter site methylation in early diagnosis of prostate cancer [J]. The Journal of Practical Medicine, 2024, 40(5): 688-694.
[6]	Hang DENG,Hao. ZHANG. Clinical application of hepatocellular carcinoma prediction models： current challenges and future directions [J]. The Journal of Practical Medicine, 2024, 40(24): 3561-3567.
[7]	Lijun LIU,Xiangyun LI,Yajuan YANG. Values of peripheral blood RDW， NLR， FAR and SP⁃A in evaluating patient condition and risks of acute exacerbation of COPD [J]. The Journal of Practical Medicine, 2024, 40(22): 3244-3250.
[8]	Shuting YANG,Shuoming LUO,Zhiguang. ZHOU. A new vision of diabetes classification： A shift from clinical manifestation to etiological molecular mechanism [J]. The Journal of Practical Medicine, 2024, 40(16): 2199-2205.
[9]	PENG Miaoguan, DENG Xuefeng. . Efficacy and safety of intravenous hormone in patients with severe AECOPD complicated with type 2 dia⁃ betes mellitus [J]. The Journal of Practical Medicine, 2022, 38(20): 2590-2596.
[10]	HE Guiqiang, ZHAO Shunshun, LANG Yanzhu, WANG Xiaojing, OUYANG Yao.. Role of secretory immunoglobulin A in chronic airway diseases：A review of recent studies [J]. The Journal of Practical Medicine, 2022, 38(20): 2620-2623.
[11]	TIAN Chen, LIU Zhihui, MENG Fanrong, LI Hua, HE Xiangrong, HU Jinxing. . Mechanism of CSE ⁃induced up ⁃regulation of MUC5AC in 16HBE cells by transcriptomics [J]. The Journal of Practical Medicine, 2022, 38(18): 2309-2317.
[12]	JIN Jiewen, LI Yanbing.. On the diagnosis and treatment of diabetic peripheral neuropathy [J]. The Journal of Practical Medicine, 2022, 38(14): 1715-1719.
[13]	LIN Chaoqun, WANG Haihong, SHA Luying, WANG Yanqing, HUANG Honglian, SHEN Jie, SONG Juyan, SHEN Xiaoping.. Classification criteria of EULAR/ACR ⁃ 2019，SLICC ⁃2012，and ACR ⁃1997：A comparative study [J]. The Journal of Practical Medicine, 2022, 38(1): 96-100.
[14]	. Effect of bio master virtual scene interactive rehabilitation combined with combined breathing training on pulmonary function recovery in elderly patients with COPD [J]. The Journal of Practical Medicine, 2021, 37(5): 681-685.
[15]	HUANG Jinhua, DENG Guosheng, ZHANG Tingting, QIN Yinyin. . Association between expression of secretory leukocyte proteinase inhibitor in airway and lung function in patients with COPD [J]. The Journal of Practical Medicine, 2021, 37(15): 1953-1957.